http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BG-1302-U1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f058a71899e153cedc18883bad5b31a
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 2009-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4513214407643018c6a3dec12af4834b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4775696095e9baa956bf1d66b9d28de2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a947852fb2a3a425f05d96f316b32b80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f821233d390676cc718d91dda9a12601
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48af86141fa8e3318f345972eb029f26
publicationDate 2010-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BG-1302-U1
titleOfInvention PHARMACEUTICAL FORM Glimepiride
abstract The utility model relates to a formulation of glimepiride containing glimepiride from 1 to 4 mg and excipients in% by weight of the tablet: lactose from 10 to 45, microcrystalline cellulose from 10 to 65, pregelatinized starch from 5 to 50 and a binder from 0.5 to 7 selected from hydroxypropylcellulose or hydroxypropylmethylcellulose, disintegrant 1 to 10 selected from croscarmellose sodium, sodium glycolate starch or crospovidone, preferably croscarmellose sodium, glidant from 0.5 to 3 or selected from furatarite magnesium stearate. The dosage form achieves a rapid degree of dissolution of the drug glimepiride and is stable when stored for 3 years. The obtained tablets are strong with good physicomechanical properties - mechanical strength and degradability. The dosage form is also convenient for pharmaceutical production, with the excipients being indifferent to the drug substance and the apparatus used and providing good technological performance.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112618499-A
priorityDate 2009-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007072218-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18009276
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591227
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453754419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414042333
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533847
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3476
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260389
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453335048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517347
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665634
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452788844

Total number of triples: 40.